Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

BACKGROUND: A number of protein markers have been investigated as prognostic adjuncts in breast cancer but their translation into clinical practice has been impeded by a lack of appropriate validation. Recently, we showed that BCL2 protein expression had prognostic power independent of current used...

Descripción completa

Detalles Bibliográficos
Autores principales: Callagy, Grace M, Webber, Mark J, Pharoah, Paul DP, Caldas, Carlos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430210/
https://www.ncbi.nlm.nih.gov/pubmed/18510726
http://dx.doi.org/10.1186/1471-2407-8-153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430210/
https://www.ncbi.nlm.nih.gov/pubmed/18510726
http://dx.doi.org/10.1186/1471-2407-8-153

Ejemplares similares